Panelists discuss how the patient’s journey with multiple myeloma begins with an initial diagnosis followed by first-line treatments and how this informs the decision to consider chimeric antigen receptor T-cell therapy as a subsequent option in their treatment path.
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Video content above is prompted by the following:
Can you share your journey with multiple myeloma, starting with your initial diagnosis and first-line treatment?
2 Commerce Drive
Cranbury, NJ 08512